Short Stocks

FBR Analyst Makes Bearish Case for Chesapeake Energy Corporation (CHK); Here’s Why

Chesapeake Energy Corporation (NYSE:CHK) announced yesterday that it has signed an agreement to sell a portion of its acreage and producing properties in its …

Canaccord Raises a Red Flag on Lululemon Athletica inc. (LULU); Here’s Why

Canaccord analyst Camilo Lyon is stepping down from the sidelines on Lululemon Athletica inc. (NASDAQ:LULU) with a new bearish forecast for the athletic …

Merrill Lynch Values GoPro Inc (GPRO) From A Bearish Perspective Despite Rise In Black Friday Sales

GoPro Inc (NASDAQ:GPRO) released a Black Friday sales announcement disclosing an over 35% year-over-year rise in the action camera giant’s camera unit sales …

Brean Capital Shines Light on Workday Inc’s (WDAY) Disappointing Guidance

Last night, Workday Inc (NYSE:WDAY) reported a stronger than expected fiscal third quarter results, as billings grew 33.5%, beating Street estimate of 31%.

Top Analyst Remains Cautious on Micron Technology, Inc. (MU) Despite Improving DRAM Market

Micron Technology, Inc. (NASDAQ:MU) recently disclosed that it believes overall demand environment to be healthy with a slowdown in supply growth over the …

This Analyst Bearish on GoPro Inc (GPRO) Despite Positive Holiday Quarter Update

Piper Jaffray analyst Erinn Murphy is out with a bearish forecast on GoPro Inc (NASDAQ:GPRO) on back of this morning’s news report noting …

Here’s Why Maxim Downgraded Momenta Pharmaceuticals, Inc. (MNTA) to Sell

Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA) shares are tumbling 4% today, with sales for its generic copaxone (glatopa), an injection designed to treat patients with …

Merrill Lynch Reiterates Underperform on Stratasys, Ltd. (SSYS) Following Media Event

Merrill Lynch analyst Wamsi Mohan is out with a bearish report on shares of Stratasys, Ltd. (NASDAQ:SSYS) after attending the Stratasys Media Event …

Why This Analyst is Putting Valeant Pharmaceuticals Intl Inc (VRX) on the Back Burner

Piper Jaffray reiterated Underperform on VRX stock; Sees 25% downside for the stock

Has the Valeant Pharmaceuticals Intl Inc (VRX) Train Left the Station? This Top Analyst Doesn’t Think So

Valeant Pharmaceuticals Intl Inc (NYSE:VRX) shares jumped over 25% yesterday, leaving investors underwhelmed. The drug maker reaffirmed its 2016 financial guidance of revenues ranging …